Precise tuning of disulphide crosslinking in mRNA polyplex micelles for optimising extracellular and intracellular nuclease tolerability
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The major issues in messenger (m)RNA delivery are rapid mRNA degradation in the extracellular and intracellular spaces, which decreases the efficiency and duration for protein expression from mRNA. Stabilization of mRNA carriers using environment-responsive crosslinkings has promises to overcome these issues. Herein, we fine-tuned the structure of disulphide crosslinkings, which are selectively cleaved in the intracellular reductive environment, using the mRNA-loaded polyplex micelles (PMs) prepared from poly(ethylene glycol)-poly(L-lysine) (PEG-PLys) block copolymers, particularly by focussing on cationic charge density after the crosslinking. Primary amino groups in PLys segment were partially thiolated in two ways: One is to introduce 3-mercaptopropionyl (MP) groups via amide linkage, resulting in the decreased cationic charge density [PEG-PLys(MP)], and the other is the conversion of amino groups to 1-amidine-3-mercaptopropyl (AMP) groups with preserving cationic charge density [PEG-PLys(AMP)]. Compared to non-crosslinked and PEG-PLys(MP) PMs, PEG-PLys(AMP) PM attained tighter mRNA packaging in the PM core, thereby improving mRNA nuclease tolerability in serum and intracellular spaces, and providing enhanced protein expression in cultured cells at the optimal crosslinking density. These findings highlight the importance of cationic charge preservation in installing crosslinking moieties, providing a rationale for mRNA carrier design in the molecular level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“Even after the uptake by target cells, mRNA is still exposed to intracellular RNases, resulting in only a transient protein expression [10,11].”
BackgroundBlock copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Self-citationmRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · cited 1×
“Messenger RNA (mRNA) has garnered increasing interest as a novel nucleic acid therapeutic that allows sustainable protein supplementation to the diseased tissues without any risk of random genomic integration [1,2].”
BackgroundBlock copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Self-citationTools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389
mRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232
Research works printed but not linked: 37
- 10.1016/j.jconrel.2015.12.032 · DOI · Paper page
- 10.1038/224329a0 · DOI
- 10.1021/bc700388u · DOI · Paper page
- 10.1073/pnas.1200718109 · DOI · Paper page
- 10.1016/j.cell.2009.01.019 · DOI · Paper page
- 10.1021/ja993057y · DOI · Paper page
- 10.1016/j.bbamcr.2007.10.013 · DOI · Paper page
- 10.1002/jgm.331 · DOI · Paper page
- 10.1093/nar/gni085 · DOI · Paper page
- 10.1002/marc.201600046 · DOI · Paper page
- 10.1016/j.ymthe.2016.10.006 · DOI · Paper page
- 10.1038/sj.gt.3301446 · DOI
- 10.1016/S0169-409X(02)00017-0 · DOI · Paper page
- 10.1021/ja0379666 · DOI · Paper page
- 10.1021/bm000142l · DOI · Paper page
- 10.1002/anie.201102165 · DOI · Paper page
- 10.1021/bm2006714 · DOI
- 10.1002/anie.201203360 · DOI · Paper page
- 10.1016/j.biomaterials.2015.10.022 · DOI
- 10.1021/jacs.7b08816 · DOI · Paper page
- 10.1021/acs.molpharmaceut.8b00134 · DOI
- 10.1021/ja506194z · DOI · Paper page
- 10.1002/anie.201707466 · DOI · Paper page
- 10.1021/acsnano.6b08447 · DOI · Paper page
- 10.1021/bc9701306 · DOI · Paper page
- 10.1039/C1CS15258K · DOI · Paper page
- 10.1371/journal.pone.0056220 · DOI · Paper page
- 10.1016/j.biomaterials.2015.12.031 · DOI
- 10.1016/j.biomaterials.2017.09.033 · DOI
- 10.1016/j.biomaterials.2011.09.046 · DOI
- 10.1021/ja00017a044 · DOI · Paper page
- 10.1016/j.freeradbiomed.2008.02.002 · DOI
- 10.1096/fj.13-235440 · DOI · Paper page
- 10.1016/S0142-9612(03)00347-8 · DOI · Paper page
- 10.1021/bm025527d · DOI
- 10.1021/bm800985e · DOI · Paper page
- 10.1002/jgm.975 · DOI
Cited by
Long non-coding RNAs: From disease code to drug role
Chen, Y., Li, Z., Chen, X., & Zhang, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.001 · Cited by 503
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Self-citationNanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139
Self-citationNanoplatforms for mRNA Therapeutics
Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000099 · Cited by 130
Metadata
- Authors
- Dirisala, A., Uchida, S., Tockary, T. A., Yoshinaga, N., Li, J., Osawa, S., Gorantla, L., Fukushima, S., Osada, K., & Kataoka, K.
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 2019-04-05
- Volume
- 27
- Issue
- 5-6
- Pages
- 670-680
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2903191912
- Cited by
- 76
- References
- 7
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Grants-in-Aid for Specially Promoted Research (25000006 to K.K.)
- Early-Career Scientists (18K18393 to A.D.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Precise tuning of disulphide crosslinking in mRNA polyplex micelles for optimising extracellular and intracellular nuclease tolerability. https://app.cochat.ai/papers/10.1080/1061186x.2018.1550646
- The paper
- Dirisala, A., Uchida, S., Tockary, T. A., Yoshinaga, N., Li, J., Osawa, S., Gorantla, L., Fukushima, S., Osada, K., & Kataoka, K. (2019). Precise tuning of disulphide crosslinking in mRNA polyplex micelles for optimising extracellular and intracellular nuclease tolerability. Journal of Drug Targeting. https://doi.org/10.1080/1061186x.2018.1550646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.